Name (print) Page 1 of 4
COVID-19 VACCINE ADMINISTRATION RECORD & CONSENT FORM
Name (Print)
Date of Birth
Address
City
State, Zip
Telephone
COVID-19 IMMUNIZATION SCREENING QUESTIONS
1. In the past two weeks, have you tested positive for COVID-19 or are
you currently being monitored for COVID-19?
Yes
No
2. In the past two weeks, have you had known contact with anyone who
has tested positive for COVID-19 or have you been instructed to
quarantine?
Yes
No
3. Do you currently have the new onset of fever, chills, cough, shortness
of breath, difficulty breathing, fatigue, muscle or body aches, headache,
new loss of taste or smell, sore throat, nausea, vomiting, or diarrhea?
Yes
No
4. Have you been administered any other vaccine within the past 14
days?
Yes
No
5. [Only answer this question if you have already received a COVID-
19 vaccine dose] After your last COVID-19 vaccine dose, did you
experience anaphylaxis, itching, swelling or respiratory distress within 4
hours of vaccine administration?
Yes
No
If you answered “Yes” to any of questions 1 – 5, the COVID-19 vaccine cannot be administered
at this time.
6. Are you sick today? (For example: cold, fever, or acute illness)
Yes
No
7. Have you ever experienced a severe allergic reaction to something,
including chemotherapy-related medications? (For example, a reaction
for which you were treated with epinephrine)
Yes
No
8. Have you ever had a serious reaction after receiving a vaccination? Do
you have a history of fainting, particularly with vaccines? Has any
physician or other healthcare professional ever cautioned or warned
you about receiving certain vaccines or receiving vaccines outside of a
medical setting?
Yes
No
9. [Only answer this question if you have already received a COVID-
19 vaccine dose] Have your answers to any of the above questions
changed since your last dose?
Yes
No
Name (print) Page 2 of 4
CONSENTS & ACKNOWLEDGEMENT
By my signature below, I acknowledge and consent as follows:
I understand that COVID-19 is a contagious viral infection of the respiratory tract that can spread from
person to person usually through close contact with an infected person or through respiratory droplets
that are dispersed into the air when an infected person coughs, sneezes, talks, or sings. Droplets can
land in the mouths or noses of people who may be close by. Spread is more likely when people are
within 6 feet of distance of each other. Infection may also occur when a person comes in contact with a
surface contaminated by the referenced droplets.
I understand that as of the date of this of this consent, vaccination is expected to be among the most
effective means of slowing the spread of the COVID-19 infection and ending the ongoing global
pandemic. Further, I understand the vaccine is intended as a two-shot series to maximize efficacy. The
second vaccine administration must be given approximately 21 or 28 days (depending on the specific
vaccine administered) after the initial administration. I also understand that between the first and second
administrations of the COVID-19 vaccine, I should not have any other vaccines administered.
I have received a copy of the COVID-19 vaccine Fact Sheet for Recipients and Caregivers and been
given an opportunity to review it prior to vaccine administration. I may also access such vaccine fact
sheet online through the U.S. Food and Drug Administration at:
www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-
vaccines
I acknowledge that such fact sheets, among other things, provide the following:
o The FDA has authorized the emergency use of the COVID-19 Vaccine
o The significant known and potential risks and benefits of the COVID-19 Vaccine, and the
extent to which such risks and benefits are unknown
o Information about available alternative vaccines and the risks and benefits of those
alternatives
I understand that the COVID-19 vaccine, like all medicines, can cause side effects. Most side effects
are mild and short-term and not everyone experiences them. Based on recent CDC guidance, I
understand that anaphylaxis, itching, swelling or respiratory distress within 4 hours of COVID-19
vaccine administration, is a contraindication for receiving a future dose of the COVID-19 vaccine. CDC
guidance also states that a second vaccine should only be considered after an evaluation by an
allergist-immunologist who would determine if I can safely receive the second vaccine. If I experience
severe side effects, I should immediately call 9-1-1 or seek medical attention. Further, I understand that
severe side effects may have to be reported to relevant regulatory authorities, and as such, I will report
all severe side effects to CTCA as the entity who administered my vaccine.
I understand that the COVID-19 vaccine is a two-part vaccine series. By signing this consent, I am
agreeing that I will receive the first and second part of the vaccine series.
Name (print) Page 3 of 4
REQUIRED INFORMATION (CHOOSE THE BEST AVAILABLE OPTION):
Race: American Indian or Alaska Native
Asian
Black or African-American
Hispanic or Latino
Native Hawaiian or Other Pacific Islander
Other race
White
Unknown
Ethnicity: Hispanic or Latino
Not Hispanic or Latino
Unknown
I have read and understand each of the above consents. Through my signature below, I voluntarily and
without coercion assume full responsibility for my decision to have the COVID-19 vaccine administered
and knowingly accept full responsibility for any reactions that may result. I release and hold my vaccine
administrator, Cancer Treatment Centers of America and its affiliated entities, harmless from and against
any and all demands, damages, losses, costs, expenses, obligations, liabilities, claims, actions and
cause of action (whether any of which is groundless or otherwise) of any nature whatsoever (including,
without limitation, reasonable attorney’s fees and court costs) by reason of or resulting, in any way, from
any and all acts, accidents, events, occurrences, omissions and the like related to, or arising out of,
directly or indirectly, for its actions administering the COVID-19 vaccine. Cancer Treatment Centers of
America and its affiliated entities make no warranties, express or implied, including but not limited to,
implied warranties of merchantability or fitness for a particular purpose regarding the vaccine or its
effectiveness.
Signature
Date
click to sign
signature
click to edit
Name (print) Page 4 of 4
Second Administration Acknowledgement
Through my signature below, I confirm that my answers to the COVID-19 Immunization Screening
Questions are unchanged as of the date of the second vaccine administration. I voluntarily and without
coercion assume full responsibility for my decision to receive the second administration of the COVID-
19 vaccine. I release and hold my vaccine administrator, Cancer Treatment Centers of America and its
affiliated entities, harmless from and against any and all demands, damages, losses, costs, expenses,
obligations, liabilities, claims, actions and cause of action (whether any of which is groundless or
otherwise) of any nature whatsoever (including, without limitation, reasonable attorney’s fees and court
costs) by reason of or resulting, in any way, from any and all acts, accidents, events, occurrences,
omissions and the like related to, or arising out of, directly or indirectly, for its actions administering the
COVID-19 vaccine. Cancer Treatment Centers of America and its affiliated entities make no warranties,
express or implied, including but not limited to, implied warranties of merchantability or fitness for a
particular purpose regarding the vaccine or its effectiveness.
Signature
Date
TO BE COMPLETED BY STAKEHOLDER/OCCUPATIONAL HEALTH REPRESENTATIVE
1
st
Administration
Vaccine Manuf. Lot # Exp. Date
Route: IM Deltoid: Left Right
Administered By: Administration Date:
2
nd
Administration
Vaccine Manuf. Lot # Exp. Date
Route: IM Deltoid: Left Right
Administered By: Administration Date: